Table 2: Association between plasma CCL5 levels (ng/mL) and tumour characteristics.

VariableStatistics
Mean ± SD Median Range value

CCL5 plasma
 pN23881,37 ± 34,6878,161,72–208,12
  012379,13 ± 33,8773,405,76–194,200.215
  15683,27 ± 37,01 84,221,72–189,28
  2/33288,34 ± 33,1989,7025,32–208,12

CCL5 plasma
 pT23881,37 ± 34,6878,161,72–208,12
  18776,16 ± 33,2773,401,72–178,000.068
  210783,22 ± 32,8084,1123,29–189,28
  3/415104,06 ± 47,5296,8643,89–208,12

CCL5 plasma
 LVI23881,37 ± 34,6878,161,72–208,12
  No15179,24 ± 35,2174,241,72–194,200.087
  Yes7287,00 ± 35,2683,6210,93–208,12

CCL5 plasma
 Multifocal23881,37 ± 34,6878,161,723–208,12
  No19480,36 ± 35,5277,481,723–208,120.364
  Yes4185,14 ± 31,3978,4824,85–178,00

values are based on a Kruskal Wallis test (no. of levels > 2).
Min: the lowest value, max: the highest value, Q1: percentile 25, Q3: percentile 75, SD: standard deviation.